
Elekta AB
Clinical solutions for treating cancer and brain disorders.
- Healthcare
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | N/A | IPO | |
Total Funding | 000k |

SEK | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (6 %) | 6 % | 16 % | 7 % | (1 %) | (1 %) | 8 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 22 % | 18 % | 15 % | 18 % | 12 % | 19 % | 20 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 9 % | 8 % | 6 % | 7 % | 1 % | 8 % | 9 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 11 % | 9 % | 8 % | 8 % | 15 % | - | - |
Source: Company filings or news article, Equity research estimates
Elekta specializes in precision radiation medicine, focusing on enhancing treatment for cancer and brain disorders. The company operates in the healthcare sector, providing advanced medical technologies to clinicians worldwide. Elekta's business model revolves around developing and distributing radiation therapy equipment and software solutions, which are designed to improve patient outcomes and streamline clinical workflows. Revenue is generated through the sale of these medical devices and associated services. Elekta serves a diverse client base, including hospitals, cancer treatment centers, and healthcare providers, aiming to expand access to radiation therapy, particularly in underserved markets. The company emphasizes sustainability and shareholder value, striving to grow its installed base of machines globally. Keywords: radiation, medicine, cancer, treatment, healthcare, equipment, software, therapy, clinicians, global.
Tech stack
Investments by Elekta AB
Edit



